
Opinion|Videos|November 17, 2023
Myelodysplastic Syndrome (MDS) Overview
Ryan Haumschild, PharmD, MS, MBA, CPEL, opens the discussion by defining the MDS disease state.
Advertisement
Episodes in this series

Now Playing
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
5 Ways ACOs Can Improve Care, Achieve Meaningful Savings
2
Long-Term Remission in Ph-Negative B-ALL With Sequential CAR T, ASCT
3
How Artificial Intelligence Is Transforming Leukemia Detection and Diagnosis
4
Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer
5













































